Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors (Q35051964)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors |
scientific article |
Statements
1 reference
Phase I dose-escalation study of buparlisib (BKM120), an oral pan-class I PI3K inhibitor, in Japanese patients with advanced solid tumors (English)
1 reference
Toshihiko Doi
1 reference
Takayuki Yoshino
1 reference
Atsushi Ohtsu
1 reference
Yuichi Ando
1 reference
Megumi Inada-Inoue
1 reference
Ayako Mitsuma
1 reference
Naoko Suenaga
1 reference
Masahiko Sato
1 reference
Tomoyuki Kakizume
1 reference
Matthew Robson
1 reference
Cornelia Quadt
1 reference
13 February 2014
1 reference
1 reference
105
1 reference
3
1 reference
347-353
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference